Pharmaceutical industry – Page 25
-
Article
Pharma and academia: a recipe for success
More big pharmaceutical companies are collaborating with universities
-
News
English health service could recover £500m in drug costs from Pfizer
NHS England may have paid over the odds for pain drug whose patent has now been revoked
-
Business
Indian court seizes former Ranbaxy owners’ assets
Daiichi Sankyo inches closer to recovering money from Singh brothers
-
Business
Chemist caught stealing and dumping cyanide
Merck & Co senior analytical chemist arrested for stealing and then dumping highly toxic substance down a curbside drain
-
Business
BMS stimulates cancer drug hopes with giant collaboration
Immunooncology pioneer will pay up to $3.6bn in hope Nektar drug will help non-responders
-
News
Illegal antibiotic combinations threaten efforts to battle antimicrobial resistance
Unapproved formulations make up two-thirds of combination therapies sold in India
-
Business
Sanofi enters M&A bonanza
French drugmaker strengthens rare diseases portfolio with blood disorder purchases
-
News
Apotex chief executive steps down amid tumult at generics firm
President and chief executive of Canada’s biggest generic drugmaker resigns the same day that police announce its founder and his wife were murdered
-
Opinion
Why modern chemists need to think big
The lessons we can learn from the larger reaction scales of the past
-
Business
Celgene takes a punt on M&A
Cancer specialist bags Juno therapeutics and Impact Biomedicines
-
Business
FDA new drug approvals more than doubled in 2017
The FDA approved 46 new drugs last year – the highest number in over two decades – due to factors like streamlined policies at the agency
-
Research
1500 reactions per day go with the flow
Automated flow chemistry system puts high-speed spin on drug discovery
-
Business
Non-profit generic drug company created
Intermountain Healthcare is leading an effort in the US to prevent drug shortages and end their skyrocketing prices
-
News
UK drug discovery model must ‘break and change’
Report calls for joined-up approach that brings together charities, industry and universities
-
Business
Dementia slips down pharma agenda
Pfizer, Shire, Acorda and Axovant rethink their neuroscience strategies
-
News
The latest lethal injection row explained
Two US states plan to use untried drugs to execute prisoners
-
Business
Teva to cut 14,000 jobs
Saddled with debt in an increasingly competitive generic drug industry, the Israel-headquartered giant begins a difficult transformation
-
Opinion
For the sake of argument
It’s important to recognise which disputes can actually be resolved by science
-
Research
Suzuki–Miyaura–hydrogenation targets 3D drugs
Researchers design a new pathway to make sp3 enriched drug molecules
-
Business
Pharmaceuticals roundup 2017
Political influence has strongly shaped industry activity in the past year